Yu-Ching Wen

13PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 11, 2024
MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT.

Yen-Nien Liu, Wei-Yu Chen, Hsiu-Lien Yeh

|Feb 21, 2024
Immunosuppressive role of BDNF in therapy-induced neuroendocrine prostate cancer.

Yen-Nien Liu, Wei-Yu Chen, Ming-Kun Liu

|Jan 29, 2024
Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.

Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen

|Aug 12, 2023
Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features.

Van Thi Ngoc Tram, Hoang Dang Khoa Ta, Gangga Anuraga

|May 04, 2023
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.

Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen

|Mar 20, 2022
Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency.

Yu-Ching Wen, Wei-Yu Chen, Van Thi Ngoc Tram

Pageof 3

Frequent Collaborators

6 joint publications

Wei-Yu Chen

5 joint publications

Michael Hsiao

5 joint publications

Jiaoti Huang

4 joint publications

Hsiu-Lien Yeh